Evidence map›Paper›PMID 37866624›Full record

ArticleJournal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer2024

The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the Revision of the N Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer.

James Huang, Raymond U Osarogiagbon, Dorothy J Giroux, Katherine K Nishimura, Andrea Bille, Giuseppe Cardillo, Frank Detterbeck, Kemp Kernstine, Hong Kwan Kim, Yolande Lievens and 14 more

Erratum issuedAbstract read
In one paragraph

Article in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 69 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Observational
  4. Review
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

James HuangThoracic Service, Memorial Sloan Kettering Cancer Center, New York, New York. Electronic address: huangj@mskcc.org.
Raymond U OsarogiagbonThoracic Oncology Research Group, Multidisciplinary Thoracic Oncology Program, Baptist Cancer Center, Memphis, Tennessee.
Dorothy J GirouxCancer Research and Biostatistics, Seattle, Washington.
Katherine K NishimuraCancer Research and Biostatistics, Seattle, Washington.
Andrea BilleDepartment of Thoracic Surgery, Guys Hospital, London, United Kingdom; School of Cancer and Pharmaceutical Sciences, Kings College University, London, United Kingdom.
Giuseppe CardilloUnit of Thoracic Surgery, Azienda Ospedaliera San Camillo-Forlanini, Rome, Italy; UniCamillus-Saint Camillus International University of Health Sciences, Rome, Italy.
Frank DetterbeckDepartment of Surgery, Yale University, New Haven, Connecticut.
Kemp KernstineDivision of Thoracic Surgery, University of Texas Southwestern Medical Center, Dallas, Texas.
Hong Kwan KimDepartment of Thoracic and Cardiovascular Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Yolande LievensRadiation Oncology Department, Ghent University Hospital and Ghent University, Ghent, Belgium.
Eric LimImperial College London, London, United Kingdom; The Academic Division of Thoracic Surgery, Royal Brompton Hospital, London, United Kingdom.
Edith MaromDepartment of Diagnostic Imaging, Chaim Sheba Medical Center, Tel-Aviv University, Ramat Gan, Israel.
Helmut ProschDepartment of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Vienna General Hospital, Vienna, Austria.
Paul Martin PutoraDepartment of Radiation Oncology, Kantonsspital St. Gallen, Switzerland; Department of Radiation Oncology, University of Bern, Switzerland.
Ramon Rami-PortaDepartment of Thoracic Surgery, Hospital Universitari Mútua Terrassa, University of Barcelona, Terrassa, Barcelona, Spain; Network of Centres for Biomedical Research in Respiratory Diseases (CIBERES) Lung Cancer Group, Terrassa, Barcelona, Spain.
David RiceDepartment of Thoracic and Cardiovascular Surgery, University of Texas, MD Anderson Cancer Center, Houston, Texas.
Gaetano RoccoThoracic Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Valerie W RuschThoracic Service, Memorial Sloan Kettering Cancer Center, New York, New York.
Isabelle OpitzDepartment of Thoracic Surgery, University Hospital Zurich, Zurich, Switzerland.
Francisco Suarez VasquezDepartment of Surgery, Clínica Santa María, Universidad de Los Andes, Santiago, Chile.
Paul Van SchilDepartment of Thoracic and Vascular Surgery, Antwerp University Hospital, Antwerp University, Antwerp, Belgium.
Chi-Fu Jeffrey YangDivision of Thoracic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, Massachusetts.
Hisao AsamuraDivision of Thoracic Surgery, Keio University School of Medicine, Tokyo, Japan.
Members of the Staging and Prognostic Factors Committee, Members of the Advisory Boards, and Participating Institutions of the Lung Cancer Domain

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Sandi Leigh Pruitt · 2010 to 2026
$53.7M
Improving pathologic nodal staging of resected lung cancerR01CA172253 · NCI · UNIVERSITY OF MEMPHIS · PI OSAROGIAGBON, RAYMOND U · 2013 to 2022
$4.8M
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA172253
6 · The paper itself

Abstract

introductionThe accurate assessment of nodal (N) status is crucial to the management and prognostication of nonmetastatic NSCLC. We sought to determine whether the current N descriptors should be maintained or revised for the upcoming ninth edition of the international TNM lung cancer staging system.

methodsData were assembled by the International Association for the Study of Lung Cancer on patients with NSCLC, detailing both clinical and pathologic N status, with information about anatomical location and individual station-level identification. Survival was calculated by the Kaplan-Meier method and prognostic groups were assessed by a Cox regression analysis.

resultsData for clinical N and pathologic N status were available in 45,032 and 35,009 patients, respectively. The current N0 to N3 descriptors for both clinical N and pathologic N categories reflect prognostically distinct groups. Furthermore, single-station N2 involvement (N2a) exhibited a better prognosis than multistation N2 involvement (N2b) in both clinical and pathologic classifications, and the differences between all neighboring nodal subcategories were highly significant. The prognostic differences between N2a and N2b were robust and consistent across resection status, histologic type, T category, and geographic region.

conclusionsThe current N descriptors should be maintained, with the addition of new subdescriptors to N2 for single-station involvement (N2a) and multiple-station involvement (N2b).

Indexed as

Lung NeoplasmsNeoplasm StagingAgedCarcinoma, Non-Small-Cell LungFemaleHumansMaleMiddle AgedPrognosisLung cancerLung cancer stagingLymph node metastasisN componentN descriptorsTNM classification

Identifiers

PMID37866624
PMCPMC12323887

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.